White Reishi (Ganoderma lucidum)
White Reishi (Ganoderma lucidum) is a medicinal mushroom containing bioactive polysaccharides, including exopolysaccharides (EPS) and intracellular polysaccharides (IPS), as primary studied compounds. Current research is largely limited to cultivation and fermentation science, with clinical evidence for human health benefits not yet established.

Origin & History
White Reishi is a pale variant of Ganoderma lucidum, a medicinal fungus in the Ganodermataceae family, cultivated on substrates like sawdust amended with wheat bran or wood logs under controlled low-light conditions that promote lighter pigmentation. It originates from East Asian traditional cultivation and is typically extracted using double-extraction methods (water boiling followed by alcohol or dehydration) to capture both water-soluble and alcohol-soluble compounds from dried fruiting bodies.
Historical & Cultural Context
Ganoderma lucidum (Reishi) has historical use in Traditional Chinese Medicine as 'Lingzhi,' valued as a medicinal mushroom. However, specific traditional context for the White Reishi cultivar variant is not documented in the available research.
Health Benefits
• No clinical health benefits documented - available research focuses solely on cultivation techniques • Traditional use suggests medicinal properties, but no evidence quality can be assigned • Polysaccharide content (3.5 g/L EPS, 4.8 g/L IPS) identified in fermentation studies, but health effects unstudied • Biological efficiency of 10-35% reported for cultivation yield, not therapeutic outcomes • Double-extraction method targets both water- and alcohol-soluble compounds, but specific benefits unverified
How It Works
White Reishi polysaccharides, including beta-glucans, are theorized to engage Toll-like receptor 2 (TLR2) and Dectin-1 receptors on macrophages and dendritic cells, potentially stimulating innate immune signaling cascades including NF-κB activation. Triterpenoids found in Ganoderma species, such as ganoderic acids, have been studied in vitro for inhibition of HMG-CoA reductase and 5-alpha reductase, though white varietal-specific data is absent. These proposed mechanisms are extrapolated from broader Ganoderma genus research and have not been confirmed in clinical trials specific to white Reishi.
Scientific Research
No human clinical trials, RCTs, or meta-analyses for White Reishi were found in the research dossier. The available literature focuses exclusively on cultivation optimization parameters such as pH 5.5, 65% moisture, and fermentation conditions rather than efficacy studies.
Clinical Summary
No clinical trials specifically investigating white Reishi (the white-pigmented variety of Ganoderma lucidum) in human subjects have been identified in the peer-reviewed literature. Available research is confined to fermentation optimization studies, with one study reporting EPS yields of 3.5 g/L and IPS yields of 4.8 g/L under controlled conditions, but without human pharmacological endpoints. Traditional Chinese and Japanese medicine attributes immunomodulatory and adaptogenic properties to Ganoderma lucidum broadly, though these claims lack randomized controlled trial support specific to the white variety. Evidence quality for any health benefit claim related to white Reishi must currently be rated as insufficient.
Nutritional Profile
White Reishi (Ganoderma lucidum) nutritional composition is primarily characterized by its bioactive compounds rather than macronutrient density. Polysaccharides (beta-glucans) are the most documented constituents: exopolysaccharides (EPS) at approximately 3.5 g/L and intracellular polysaccharides (IPS) at approximately 4.8 g/L as identified in fermentation studies. General Ganoderma genus data indicates dried fruiting body contains approximately 10-40% total polysaccharides by dry weight, 10-20% crude protein, 2-8% crude fat, 3-5% crude fiber, and 60-80% total carbohydrates by dry weight. Triterpenes (ganoderic acids) are present in the fruiting body, estimated at 1-3% by dry weight in the broader Ganoderma lucidum species — these are lipid-soluble bitter compounds concentrated in the outer surface. Minerals documented in the Ganoderma genus include potassium (estimated 1,000-2,000 mg/100g dry weight), phosphorus, calcium, magnesium, and trace amounts of zinc, iron, and selenium, though white strain-specific mineral data is absent. Ergosterol (provitamin D2 precursor) is present as in most fungi, with concentrations varying by light exposure during cultivation. Bioavailability note: polysaccharide absorption is limited without processing; hot water extraction significantly increases bioavailability of beta-glucans. Health implications of these concentrations in white Reishi specifically remain unstudied per available literature.
Preparation & Dosage
No clinically studied dosage ranges are available for White Reishi. Cultivation studies report polysaccharide yields in fermentation (3.5 g/L EPS, 4.8 g/L IPS, or 68.5 g/kg in dry powders) but do not translate to consumption recommendations. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
No synergistic ingredients identified in research
Safety & Interactions
White Reishi has no documented clinical safety profile specific to the white variety; general Ganoderma lucidum use has been associated with dry mouth, dizziness, gastrointestinal upset, and rare hepatotoxicity cases in powdered supplement form. Due to potential immunomodulatory activity via beta-glucan pathways, caution is advised for individuals on immunosuppressant medications such as cyclosporine or corticosteroids. Antiplatelet and anticoagulant drug interactions (e.g., warfarin, aspirin) have been noted anecdotally with Ganoderma genus products due to possible platelet aggregation inhibition. Safety during pregnancy and lactation has not been evaluated, and use is not recommended in these populations without medical supervision.